Cyprodenate: Difference between revisions
Tools
Actions
General
Print/export
Print/export
In other projects
From Wikipedia, the free encyclopedia
No edit summary |
→Infobox: Simplify SMILES from O=C(abcdef)ghijk to fedcbaC(=O)ghijk, i.e.start at end of molecule rather than middle to avoid nexted parens. |
||
Line 28: | Line 28: | ||
| C=13 | H=25 | N=1 | O=2 |
| C=13 | H=25 | N=1 | O=2 |
||
| molecular_weight = 227.34 |
| molecular_weight = 227.34 |
||
| smiles = O=C(OCCN(C)C)CCC1CCCCC1 |
| smiles = CN(C)CCOC(=O)CCC1CCCCC1 O=C(OCCN(C)C)CCC1CCCCC1 |
||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C13H25NO2/c1-14(2)10-11-16-13(15)9-8-12-6-4-3-5-7-12/h12H,3-11H2,1-2H3 |
| StdInChI = 1S/C13H25NO2/c1-14(2)10-11-16-13(15)9-8-12-6-4-3-5-7-12/h12H,3-11H2,1-2H3 |
Revision as of 03:51, 27 July 2017
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
KEGG |
|
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.036.025 |
Chemical and physical data | |
Formula | C13H25NO2 |
Molar mass | 227.34 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Cyprodenate (Actebral) is a stimulant drug.[1] It was used for counteracting the effects of benzodiazepine tranquillizer drugs before the development of newer antidotes such as flumazenil.[2] It produces dimethylethanolamine as a metabolite, and so might be expected to produce nootropic effects.
See also
References
- ^ Dormard Y, Levron JC, Le Fur JM. Pharmacokinetic study of maleate acid of 2-(N,N-dimethylaminoethanol-14C1)-cyclohexylpropionate (cyprodenate) and of N,N-dimethylaminoethanol-14C1 in animals. Arzneimittelforschung. 1975 Feb;25(2):201–7. PMID 1173033.
- ^ Bobkov Yu.G., Morozov I.S.. Correction of psychodepressive effects of benzodiazepine tranquilizers by administration of psychoenergizers. Bulletin of Experimental Biology and Medicine. 1982 Oct;94(4):1366-1369. English. doi:10.1007/BF00827201.
DRAsTooltip Dopamine releasing agents |
| ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NRAsTooltip Norepinephrine releasing agents |
| ||||||||||||||
SRAsTooltip Serotonin releasing agents |
| ||||||||||||||
Others |
| ||||||||||||||
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |